Evolving Landscape of Respiratory Viral Infections in Hematopoietic Cellular and CAR T-cell Therapy Recipients Post-COVID-19 Pandemic
Posted inHematology-Oncology Infectious Diseases news

Evolving Landscape of Respiratory Viral Infections in Hematopoietic Cellular and CAR T-cell Therapy Recipients Post-COVID-19 Pandemic

This study elucidates the incidence and characteristics of respiratory viral infections (RVIs) within 100 days following hematopoietic cell transplant and CAR T-cell therapy, highlighting SARS-CoV-2 as the predominant pathogen and identifying risk factors for severe infection in the post-pandemic era.